Tezepelumab as add‐on treatment for severe asthma. Issue 3 (13th March 2023)
- Record Type:
- Journal Article
- Title:
- Tezepelumab as add‐on treatment for severe asthma. Issue 3 (13th March 2023)
- Main Title:
- Tezepelumab as add‐on treatment for severe asthma
- Authors:
- Chaplin, Steve
- Abstract:
- Abstract : Tezepelumab (Tezspire) is a new monoclonal antibody therapy for add‐on treatment in adolescents and adults with inadequately controlled severe asthma. This article outlines its mode of action, indication and clinical trial outcomes.
- Is Part Of:
- Prescriber. Volume 34:Issue 3(2023)
- Journal:
- Prescriber
- Issue:
- Volume 34:Issue 3(2023)
- Issue Display:
- Volume 34, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 34
- Issue:
- 3
- Issue Sort Value:
- 2023-0034-0003-0000
- Page Start:
- 13
- Page End:
- 14
- Publication Date:
- 2023-03-13
- Subjects:
- Chemotherapy -- Periodicals
Drugs -- Prescribing -- Periodicals
615.1 - Journal URLs:
- http://www.prescriber.co.uk/view/0/index.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/psb.2050 ↗
- Languages:
- English
- ISSNs:
- 0959-6682
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6609.700100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26286.xml